|
|
|
|
||
OPTR exploring sale(Reuters) - Optimer Pharmaceuticals Inc (OPTR.O) said it was exploring a possible sale of the company among a full range of alternatives and that Chairman Henry McKinnell would act as chief executive for the duration of the review process. Optimer shares were up 11.6 percent at $11.95 in premarket trading. McKinnell will replace Pedro Lichtinger, who has been at the helm since 2010. |
return to message board, top of board |